AXIN2 and Familial prostate cancer: For example, E•Pinarbasi et al. [16] reported that rs2240308 polymorphism had no significant correlation with the susceptibility of prostate cancer in the Turkish population, whereas Xu et al. [17] revealed that AXIN2 rs2240308 variants may be associated with decreased cancer susceptibility.